BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20191307)

  • 1. Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells.
    Roseanu A; Florian PE; Moisei M; Sima LE; Evans RW; Trif M
    Biometals; 2010 Jun; 23(3):485-92. PubMed ID: 20191307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation.
    Coimbra M; Banciu M; Fens MH; de Smet L; Cabaj M; Metselaar JM; Storm G; Schiffelers RM
    J Control Release; 2010 Dec; 148(3):303-10. PubMed ID: 20869410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
    Banciu M; Schiffelers RM; Fens MH; Metselaar JM; Storm G
    J Control Release; 2006 Jun; 113(1):1-8. PubMed ID: 16707187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
    Hwang TL; Lee WR; Hua SC; Fang JY
    J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved antitumor activity of cis-Bis-neodecanoato-trans-R,R-1,2- diaminocyclohexaneplatinum (II) entrapped in long-circulating liposomes.
    Li S; Khokhar AR; Perez-Soler R; Huang L
    Oncol Res; 1995; 7(12):611-7. PubMed ID: 8704278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro impact of a whey protein isolate (WPI) and collagen hydrolysates (CHs) on B16F10 melanoma cells proliferation.
    Castro GA; Maria DA; Bouhallab S; Sgarbieri VC
    J Dermatol Sci; 2009 Oct; 56(1):51-7. PubMed ID: 19695839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bovine milk lactoferrin on human breast cancer cell lines.
    Duarte DC; Nicolau A; Teixeira JA; Rodrigues LR
    J Dairy Sci; 2011 Jan; 94(1):66-76. PubMed ID: 21183018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A; Mitrus I; Smolarczyk R; CichoĊ„ T; Snietura M; Czaja M; Szala S
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III.
    Park YS; Hakomori S; Kawa S; Ruan F; Igarashi Y
    Cancer Res; 1994 Apr; 54(8):2213-7. PubMed ID: 8174128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
    J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
    Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
    Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
    Stover TC; Sharma A; Robertson GP; Kester M
    Clin Cancer Res; 2005 May; 11(9):3465-74. PubMed ID: 15867249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors.
    Szala S; Missol E; Sochanik A; Strozyk M
    Gene Ther; 1996 Nov; 3(11):1026-31. PubMed ID: 9044744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines.
    Brohem CA; Sawada TC; Massaro RR; Almeida RL; Rivelli DP; Ropke CD; da Silva VV; de Lima TM; Curi R; Barros SB; Maria-Engler SS
    Toxicol In Vitro; 2009 Feb; 23(1):111-9. PubMed ID: 19059332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
    Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
    J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
    Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
    Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.